2 weeks Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy? Zacks

Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings · Pharmaceuticals